Sign up to save your podcasts
Or
Share Biosimilar therapy for breast cancer, zoledronic acid for bone metastases, the future of Obamacare under Donald Trump, and more
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biosimilar therapy for breast cancer, zoledronic acid for bone metastases, the future of Obamacare under Donald Trump, and more
Editors' Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor of JAMA, the Journal of the American Medical Association, for the January 3, 2017 issue
View all episodes
By JAMA Network
3.9
127127 ratings
Editors' Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor of JAMA, the Journal of the American Medical Association, for the January 3, 2017 issue
More shows like JAMA Editors' Summary
View all
NEJM This Week
316 Listeners
AFP: American Family Physician Podcast
697 Listeners
JAMA Clinical Reviews
497 Listeners
This Week in Cardiology
883 Listeners
Mayo Clinic Talks
297 Listeners
Frankly Speaking About Family Medicine
260 Listeners
The Curbsiders Internal Medicine Podcast
3,349 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Critical Care Scenarios
262 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners
The Curious Clinicians
370 Listeners
Critical Care Time
273 Listeners